EN
HI
Summary
As of 20 Sep, 2026, Mankind Pharma stock price is ₹2300.7. During the trading session, the stock has moved between an intraday low of ₹2287.70 and an intraday high of ₹2329.50. Over the last 52 weeks, Mankind Pharma has traded between ₹1909.70 and ₹2674.00.
The stock has recorded a trading volume of 4,84,552 shares,. Its Average Traded Price (ATP) is ₹2313.14, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹2300.70.
Mankind Pharma has an upper circuit limit of ₹2530.70 and a lower circuit limit of ₹2070.70. The total value traded stands at ₹112.08 CR, and the delivery percentage for the day is 69.19%.
The stock is currently traded with a market lot size of 1. Mankind Pharma also offers a dividend yield of 0.04%.
Mankind Pharma Share Price Chart
Mankind Pharma Share Key Metrics
Volume
4.85 L
Market Cap
95017.98 CR
LTQ@LTP
3@2300.70
ATP
2313.14
Var Margin
14.14 %
Circuit Range
2070.7-2530.7
Delivery %
69.19 %
Value
112.08 CR
ASM/GSM
No
Market Lot
1
Mankind Pharma Fundamentals
P/E Ratio
46.87
P/B Ratio
5.69
Div. Yield
0.04
Sector P/E
42.35
Sector P/B
3.61
Sec. Div. Yield
0.51
Mankind Pharma Resistance and Support
Pivot 2283.63
Resistance
First Resistance
2325.16
Second Resistance
2350.33
Third Resistance
2391.86
Support
First Support
2258.46
Second Support
2216.93
Third Support
2191.76
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
29SEP26
2327.40
17.60 (0.76%)
27OCT26
2342.90
20.80 (0.90%)
23NOV26
2349.10
30.70 (1.32%)
MANKIND|29SEP26 CE 2300.00
48.05
6.1 (14.54%)
MANKIND|29SEP26 PE 2320.00
35.95
-7.3 (-16.88%)
Mankind Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 2300 | 2300.7 | 0.03% | 2329.5 | 2287.7 |
| Thu Sep 17 2026 | 2252.69 | 2300 | 2.40% | 2308.8 | 2242.1 |
| Wed Sep 16 2026 | 2280.5 | 2246 | -1.51% | 2300.69 | 2246 |
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Intimation Regarding ESG Rating
Mankind Pharma has received an ESG rating of 68.21, categorized as 'Leader', from Niche99 ESG Ratings. This rating, for FY 2025-26, was independently prepared by Niche99 based on publicly available data.
Sep 15 2026 19:50:16
Mankind Pharma Ltd - 543904 - Update On Voluntary Liquidation Of WOS
Mankind Pharma's wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), received shareholder approval for its voluntary liquidation at an EGM held on September 7, 2026. This move follows preparatory activities initiated earlier and is contingent on approval from BSVL's creditors as per the Insolvency and Bankruptcy Code, 2016.
Sep 07 2026 17:12:32
Read More
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Max Healthcare Institute Ltd.
1049.30
12.30 (1.19%)
Dr. Reddy's Laboratories Ltd.
1185.00
10.00 (0.85%)
Aurobindo Pharma Ltd.
1734.00
44.00 (2.60%)
Manipal Health Enterprises Ltd.
738.95
17.40 (2.41%)
Lupin Ltd.
2083.00
-15.10 (0.72%)
Glenmark Pharmaceuticals Ltd.
2447.40
31.40 (1.30%)
Fortis Healthcare Ltd.
886.00
-0.10 (0.01%)
Aster DM Quality Care Ltd.
755.05
-5.60 (0.74%)
Alkem Laboratories Ltd.
5466.50
118.00 (2.21%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2300.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 46.87. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 5.69. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 95017.98 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2674.00 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MANKIND
